The Chief Medical Officer for Wales has published an update offering summaries of current news, guidance, and development on a broad range of issues relevant to health service quality and population health improvement.
In amongst the package of wide ranging updates, the Chief Medical Officer (CMO), Frank Atherton, provides an update on the performance of the All Wales Medicines Strategy Group (AWMSG).
This includes updates on:
- The All Wales Antimicrobial In-patient Medication Administration Record
- The All Wales COPD Management and Prescribing Guideline
- National Prescribing Indicators 2018-2019: Analysis of Prescribing Data to December 2018
- Therapeutic Priorities and CEPP Summary 2019-2020
- AWMSG advice
Read the CMO’s update here.